Skip to main content
Top
Published in: Acta Diabetologica 6/2016

01-12-2016 | Case Report

Blood levels of pro-inflammatory and anti-inflammatory cytokines in a patient with a flat glucose curve

Authors: Roberto Barbosa Bazotte, Any de Castro Ruiz Marques, Maria Angélica Rafaini Covas Pereira da Silva, Tuane Krupek, Wilson Eik Filho

Published in: Acta Diabetologica | Issue 6/2016

Login to get access

Excerpt

It is well established that postprandial elevations of glycemia are associated with increased plasma concentrations of pro-inflammatory cytokines [1, 2]. In agreement with this affirmation, it was demonstrated that glucose elevation initiates epigenetic changes in gene promoters that may lead to continuous inflammation following acute elevation of glycemia [3]. …
Literature
2.
go back to reference Daniele G, Mendoza RG, Winnier D et al (2014) The inflammatory status score including IL-6, TNF-α, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus. Acta Diabetol 51(1):123–131. doi:10.1007/s00592-013-0543-1 CrossRefPubMed Daniele G, Mendoza RG, Winnier D et al (2014) The inflammatory status score including IL-6, TNF-α, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus. Acta Diabetol 51(1):123–131. doi:10.​1007/​s00592-013-0543-1 CrossRefPubMed
4.
6.
go back to reference Nolfe G, Spreghini MR, Sforza RW, Morino G, Manco M (2012) Beyond the morphology of the glucose curve following an oral glucose tolerance test in obese youth. Eur J Endocrinol 166:107–114. doi:10.1530/EJE-11-0827 CrossRefPubMed Nolfe G, Spreghini MR, Sforza RW, Morino G, Manco M (2012) Beyond the morphology of the glucose curve following an oral glucose tolerance test in obese youth. Eur J Endocrinol 166:107–114. doi:10.​1530/​EJE-11-0827 CrossRefPubMed
10.
go back to reference Mancilla-Ramírez J, Ramírez-Herrera M, Portillo-Gómez L, Gaitán-Meza J, Dinarello CA (1993) Antagonists in neonatal sepsis. Bol Med Hosp Infant Mexico 50(9):691–693 Mancilla-Ramírez J, Ramírez-Herrera M, Portillo-Gómez L, Gaitán-Meza J, Dinarello CA (1993) Antagonists in neonatal sepsis. Bol Med Hosp Infant Mexico 50(9):691–693
12.
13.
go back to reference Dandona P, Aljada A, Mohanty P (2002) The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm. Diabetologia 45(6):924–930CrossRefPubMed Dandona P, Aljada A, Mohanty P (2002) The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm. Diabetologia 45(6):924–930CrossRefPubMed
14.
go back to reference Ghanim H, Abuaysheh S, Sia CL et al (2009) Increase in plasma endotoxin concentrations and the expression of Toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance. Diabetes Care 32(12):2281–2287. doi:10.2337/dc09-0979 CrossRefPubMedPubMedCentral Ghanim H, Abuaysheh S, Sia CL et al (2009) Increase in plasma endotoxin concentrations and the expression of Toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance. Diabetes Care 32(12):2281–2287. doi:10.​2337/​dc09-0979 CrossRefPubMedPubMedCentral
Metadata
Title
Blood levels of pro-inflammatory and anti-inflammatory cytokines in a patient with a flat glucose curve
Authors
Roberto Barbosa Bazotte
Any de Castro Ruiz Marques
Maria Angélica Rafaini Covas Pereira da Silva
Tuane Krupek
Wilson Eik Filho
Publication date
01-12-2016
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 6/2016
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-016-0883-8

Other articles of this Issue 6/2016

Acta Diabetologica 6/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine